Tag Archives: TSXV

BlissCo Cannabis

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

TORONTO, Ontario, Feb. 26, 2018 /Weed Wire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE), is pleased to announce that it has completed a $3,000,000 strategic equity investment (the “Investment”) in BlissCo Cannabis Corp. (“BlissCo”).

BlissCo Cannabis

Supreme Secures Supply Agreement with Namaste

TORONTO, Ontario, Jan. 25, 2018 /Weed Wire/ – The Supreme Cannabis Company, Inc. (the “Company” or “Supreme”) (TSXV:FIRE), is pleased to announce that its wholly-owned subsidiary, 8528934 Canada Ltd. (“7ACRES”), has entered into a Definitive Supply Agreement (the “Agreement”) with Cannmart, Inc. (“Cannmart”) a wholly-owned subsidiary of Namaste Technologies Inc.

Fourth Company Named as New Brunswick Recreational Cannabis Supplier

Fourth Company Named as New Brunswick Recreational Cannabis Supplier

With the Picture Province estimating that recreational legalization will create hundreds of new jobs and generate up to $150 million annually in recreational sales, the province has named the fourth New Brunswick recreational cannabis supplier.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Receives $26.5 Million from Exercise of Warrants and Triggers Acceleration of 721,700 Remaining $2.00 Warrants

VICTORIA, British Columbia, Dec. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald” or the “Company”) (TSXV: EMH; OTCQX: EMHTF) has elected to exercise its right to accelerate the exercise of $2.00 common share purchase warrants (“Warrants”) issued by the Company on February 10, 2017.

BlissCo Cannabis

Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that is has changed its name to “The Supreme Cannabis Company, Inc.” effective today. The name change was approved by the shareholders of the Company at the annual general and special meeting of shareholders held earlier today.

BlissCo Cannabis

Supreme Purchases Adjacent Land for Ultra-Premium Cannabis Facility

TORONTO, Ontario, Dec. 18, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme or the “Company”) (TSXV:FIRE) is pleased to announce the purchase of an approximately six acre property adjacent to the 7ACRES facility in Kincardine, Ontario.

Emerald Health Northern Vine Labs

Northern Vine Labs Expands Dealer’s License with Health Canada

VICTORIA, British Columbia, Dec. 15, 2017 /Weed Wire/ — Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE: ATT; OTC: ATTBF), today announced that Health Canada has approved an amendment to the Company’s dealer’s license.

Emerald Health Northern Vine Labs

Emerald Health Announces No Material Change

VICTORIA, British Columbia, Dec. 13, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

VICTORIA, British Columbia, Nov. 29, 2017 /Weed Wire/ — Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fouth Facility

VICTORIA, British Columbia, Nov. 28, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) announced today that its licensed producer application (submitted through its subsidiary, Emerald Health Botanicals) for its new Richmond, BC greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (“OMC”).

BlissCo Cannabis

Supreme Signs High-Quality Flower Supply LOI Agreement with ABLE BC.

TORONTO, Ontario, Nov. 24, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce it has entered into a Letter of Intent (“LOI”) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing BC’s private liquor industry.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

VICTORIA, British Columbia, Nov. 21, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. (“Northern Vine”) to acquire 53% of the company and appoint three of its four directors.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance

VICTORIA, British Columbia, Nov. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) today announced the appointment of Robert C. Hill, CPA, CA, as the Company’s Chief Financial Officer and the promotion of Cheryl L. Evans, CPA, CA, to Vice President Finance.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility

RICHMOND, British Columbia, Nov. 15, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (”OMC”).

BlissCo Cannabis

Supreme Pharmaceuticals Closes $40.25 Million Bought Deal Private Placement of Convertible Debenture Units

TORONTO, Ontario, Nov. 14, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce the closing of its previously announced bought deal private placement of 40,250 convertible debenture units (the “Convertible Debenture Units”), including the exercise of the Underwriters’ over-allotment option (the “Offering”), with a syndicate of underwriters, led by Canaccord Genuity Corp., including Beacon Securities Limited, Cormark Securities Inc., Eight Capital, GMP Securities L.P., and PI Financial Corp., for gross proceeds of approximately $40.25 million.

BlissCo Cannabis

Supreme Commences Production in New Flowering Rooms

TORONTO, Ontario, Nov. 7, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada.

BlissCo Cannabis

Supreme Receives Approval for Increased Capacity at 7ACRES Hybrid Facility

TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) announced today that 7ACRES has obtained the Health Canada approvals necessary to commence cultivation at the recently completed 30,000 sq. ft. flowering rooms at the Company’s Hybrid facility.

Emerald Health Northern Vine Labs

Emerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018

VICTORIA, British Columbia, Oct. 19, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH; OTCQX: EMHTF), through Emerald Health Botanicals Inc. (“Emerald”), its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has submitted license applications to Health Canada for approval of two new growing sites.

BlissCo Cannabis

Supreme Pharmaceuticals Announces $30 Million Bought Deal Private Placement of Convertible Debenture Units

TORONTO, Ontario, Oct. 17, 2017 /Weed Wire/ – Supreme Pharmaceuticals Inc. (the “Company”) (TSXV:FIRE) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, $30,000,000 aggregate principal amount of convertible debenture units (the “Convertible Debenture Units”) at a price of $1,000 per Convertible Debenture Unit.

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.

This Is Why the North American Marijuana Index Increased 6% in September

This Is Why the North American Marijuana Index Increased 6% in September

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 6% in September on strong Canadian momentum.

bayfield strategy 7ACRES Hybrid Facility

Supreme to Quadruple Capacity at 7ACRES Hybrid Facility

TORONTO, Ontario, Oct. 4, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that 7ACRES has completed construction of three additional 10,000 sq. ft. flowering rooms at its Hybrid Facility, and applied to Health Canada for licensing.

Emblem Corp

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

PARIS, Ontario, Oct. 3, 2017 /Weed Wire/ — Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto.

bayfield strategy 7ACRES Hybrid Facility

Supreme Engages Leading Financial Communications Firm Bayfield Strategy

TORONTO, Ontario, Sept. 28, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce that it has retained Bayfield Strategy, Inc. (“Bayfield”) to provide comprehensive Investor and Public Relations.

SP Fire Emerald Health Leadership Team

Supreme Strengthens Leadership Team to Prepare for Next Stage of Growth

TORONTO, Ontario, Sept. 26, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce exciting changes and additions to our senior leadership team as the Company prepares for growth.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals

VICTORIA, British Columbia, Sept. 20, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (EHT) (TSXV: EMH; OCTQX: EMHTF) today announced that its wholly owned subsidiary, Emerald Health Botanicals Inc., has completed a purchase of dried cannabis from Supreme Pharmaceuticals Inc.’s (Supreme) (TSXV: FIRE) subsidiary, 7ACRES.

SP Fire Emerald Health Leadership Team

Supreme Completes Sale with Emerald Health Botanicals Inc.

TORONTO, Ontario, Sept. 20, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products

VICTORIA, British Columbia, Sept. 18, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (Therapeutics) (TSXV: EMH; OCTQX: EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried flower product.

Two Public Companies to Supply New Brunswick Recreational Marijuana

Two Public Companies to Supply New Brunswick Recreational Marijuana

On Sept. 15, 2017, the Canadian province of New Brunswick announced during a news conference that Organigram (TSXV:OGI) and Canopy Growth (TSX: WEED), both already licensed producers in Canada’s medical marijuana program, will distribute recreational marijuana to retail stores established by a newly created provincial crown corporation.

Cronos Group Responds to Health Canada Testing

Cronos Group Responds to Health Canada Testing

TORONTO, Ontario, May 5, 2017 /Weed Wire/ – Cronos Group Inc.’s (TSXV:MJN) wholly owned licensed producer, the Peace Naturals Project Inc. (“Peace”), was notified on May 4, 2017 by Health Canada that upon testing a random cannabis leaf sample, trace levels of Piperonyl Butoxide (PBO) were discovered at 0.78 parts per million (ppm). PBO is an organic compound known as a synergist.

Marijuana Index Fell 9% in April as US and Canadian Stocks Sell Off

Marijuana Index Fell 9% in April as US and Canadian Stocks Sell Off

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 9% in April due primarily to heavy losses in the United States.

Emerald Health

Emerald Launches Market Leading CBD Oil and Supports Proposed Cannabis Legislation

VICTORIA, British Columbia, April 17, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH) (“Emerald” or the “Company”) today announced the launch of its CBD-25< and CBD-50 medical cannabis oils containing 25mg and 50mg of CBD per ml.

Legalization Anticipation: Canadian Cannabis Stocks Gain 12.3% on Monday

Legalization Anticipation: Canadian Cannabis Stocks Gain 12.3% on Monday

While the Canadian Marijuana Index dipped slightly in March due to federal uncertainties, the Canadian public markets have bounced back today on the news of recreational marijuana legislation being introduced in Canada’s House of Commons this Thursday, April 13, 2017.

Marijuana Index Drops 2% as Canadian Stocks Dip With Federal Uncertainty

Marijuana Index Drops 2% as Canadian Stocks Dip With Federal Uncertainty

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 2% in March as losses in Canada overtook modest gains in the U.S.

Aurora Cannabis operational update

Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO

VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.

Aurora Cannabis operational update

Aurora Cannabis Appoints Neil Belot Chief Global Business Development Officer

VANCOUVER, British Columbia, March 21, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that Neil Belot has been promoted to Chief Global Business Development Officer.

Aurora Cannabis operational update

Aurora to Acquire Peloton Pharmaceuticals Inc.

VANCOUVER, British Columbia, March 6, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”).

Aurora Cannabis operational update

Aurora Cannabis Expands E-commerce Strategy With Launch of Second Generation Mobile App

VANCOUVER, British Columbia, March 1, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM), today unveiled the second generation of its popular mobile application, incorporating a number of enhanced features to provide a significantly upgraded user experience to new and existing clients of the Company.

icclogo

ICC Enters Into MOU and Presale Agreement With Emblem Corp. Setting in Motion a Framework for the Importation pf CBD Into Canada

VANCOUVER, British Columbia, Feb. 27, 2017 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) is pleased to announce that it has entered into a memorandum of understanding and presale agreement (the “MOU and Presale Agreement”) with Emblem Corp. (TSXV: EMC; OTCQB: EMMBF), who through a wholly-owned subsidiary, is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations overseen by Health Canada.

Aurora Cannabis operational update

Aurora Cannabis and Radient Technologies Provide Update on Exclusive Collaboration Arrangements

VANCOUVER, British Columbia, Feb. 13, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies (“Radient”) (TSXV: RTI) are pleased to provide an update on their previously announced collaboration arrangements.

Aurora Cannabis operational update

Aurora Receives Health Canada License to Sell Cannabis Oils

VANCOUVER, British Columbia, Jan. 23, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils.

Aurora Cannabis operational update

Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales

VANCOUVER, British Columbia, Jan. 16, 2017 /Weed Wire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.

icclogo

International Cannabis Corporation Announces Incorporation of Additional Land to Increase Production Capacity

VANCOUVER, British Columbia, Dec. 20, 2016 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) has entered into an agreement to lease approximately 9 hectares of additional land adjacent to the Company’s existing property used for the production of cannabinoid extracts and by-products for medicinal use and industrial hemp.

Tweed JA

Canopy Growth Enters Into Agreement to Acquire Mettrum

SMITH FALLS, Ontario, Dec. 1, 2016 /Weed Wire/ — Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or the “Company”) and Mettrum Health Corp. (“Mettrum”) (TSXV: MT) are pleased to announce that they have entered into a definitive arrangement agreement.


Page 1 of 212
Top